(Q38014773)

27 August 2017

title

Quality-improvement guidelines for hepatic transarterial chemoembolization (English)

1 reference

27 August 2017

Antonio Basile

1

1 reference

27 August 2017

Gianpaolo Carrafiello

2

1 reference

27 August 2017

Anna Maria Ierardi

3

1 reference

27 August 2017

Dimitrios Tsetis

4

1 reference

27 August 2017

Elias Brountzos

5

1 reference

27 August 2017

publication date

31 May 2012

1 reference

CardioVascular and Interventional Radiology

27 August 2017

published in

1 reference

27 August 2017

volume

35

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

765-774

1 reference

TACE versus TAE as therapy for hepatocellular carcinoma

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Drug-loaded microspheres for the treatment of liver cancer: review of current results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Antibiotic prophylaxis in interventional radiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Adjustment of lipiodol dose according to tumor blood supply during transcatheter arterial chemoembolization for large hepatocellular carcinoma by multidetector helical CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Transcatheter arterial chemoembolization for hepatocellular carcinomas in patients with celiac axis occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Modified RECIST (mRECIST) assessment for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-012-0423-Z

10.1007/S00270-012-0423-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1013848969

0 references

1 reference